Huda Salman MD
Hematologic Oncology
Associate Professor, Internal Medicine, Stony Brook University School of Medicine
Join to View Full Profile
Nicolls RdStony Brook, NY 11794
Dr. Salman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1999 - 2002
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1996 - 1999
University of Jordan Faculty of MedicineClass of 1991
Certifications & Licensure
IN State Medical License 2021 - 2025
NY State Medical License 2015 - 2022
GA State Medical License 2013 - 2016
VA State Medical License 2011 - 2014
OH State Medical License 2009 - 2012
MO State Medical License 2006 - 2010
TN State Medical License 2005 - 2007
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014, 2017-2018
Clinical Trials
- CD4CAR for CD4+ Leukemia and Lymphoma Start of enrollment: 2020 Jul 09
Publications & Presentations
PubMed
- 60 citationsA compound chimeric antigen receptor strategy for targeting multiple myeloma.Kevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, Xiao Shuai
Leukemia. 2018-02-01 - 58 citationsA phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML, or AML with ⩽ 30% blasts.G. Garcia-Manero, Mikkael A. Sekeres, Miklos Egyed, Massimo Breccia, Carlos Graux
Leukemia. 2017-05-26 - 146 citationsPreclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptorKevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, K. W. Lin
Leukemia. 2017-01-12
Journal Articles
- SALL1 expression in acute myeloid leukemiaiao Shuai,2,3,* Anh Thu Nguyen-Lefebvre,1,* Banabihari Giri,1 Mingqiang Ren,1 Michael Rauchman,4 Lynn Robbins,4 Wei Hou,2 Hasan Korkaya,1 and Yupo Ma2, Oncotarget, 1/26/2018
Press Mentions
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New YorkJuly 13th, 2021
First in-Human Clinical Trial Targeting CD4 Protein for Aggressive T-cell Leukemia and Lymphoma to Be LaunchedAugust 7th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
